Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
Frontiers in Neurology|August 28, 2024
Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)Soon-Tae Lee, Hesham Abboud, Sarosh R Irani, et al.
Annals of Neurology|January 18, 2025
Immunotherapy-Resistant Neuropathic Pain and Fatigue Predict Quality-of-Life in Contactin-Associated Protein-Like 2 Antibody DiseaseBryan Ceronie, Christine Strippel, Christopher Uy, et al.
Brain : a Journal of Neurology|December 23, 2017
The importance of early immunotherapy in patients with faciobrachial dystonic seizuresJulia Thompson, Mian Bi, Andrew G Murchison, et al.
Journal of Clinical Immunology|October 21, 2020
IRAK4 Deficiency Presenting with Anti-NMDAR Encephalitis and HHV6 ReactivationShiho Nishimura, Yoshiyuki Kobayashi, Hidenori Ohnishi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2022
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International PerspectiveThomas Rossor, E Ann Yeh, Yasmin Khakoo, et al.
Brain : a Journal of Neurology|June 21, 2022
Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1Jorge Ramirez-Franco, Kévin Debreux, Johanna Extremet, et al.
The American Journal of Tropical Medicine and Hygiene|November 19, 2024
A Cost of Illness Analysis of Children with Encephalitis Presenting to a Major Hospital in VietnamNguyen Hoang Thien Huong, Nguyen Duc Toan, Truong Huu Khanh, et al.
The Cochrane Database of Systematic Reviews|October 19, 2012
Collaboration between local health and local government agencies for health improvementSara L Hayes, Mala K Mann, Fiona M Morgan, et al.
The Lancet. Infectious Diseases|October 19, 2010
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyJulia Granerod, Helen E Ambrose, Nicholas Ws Davies, et al.
Immunity|June 15, 2024
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathiesBarney Viengkhou, Emina Hayashida, Sarah McGlasson, et al.
Pageof 19